Osteoporosis Care in Sherman, Texas, at DFWPMA

What Osteoporosis and Bone Health Conditions Can Be Managed at DFWPMA Sherman?

Osteoporosis care at DFWPMA Sherman addresses reduced bone mineral density, elevated fracture risk, and medical conditions that may weaken the skeleton over time. Specialized endocrinology evaluations can help adults and older adults understand the causes of bone loss and determine appropriate treatment options.

Common bone health concerns that may require endocrinology care include:

• Postmenopausal Osteoporosis: Bone loss associated with reduced estrogen production after menopause, which can increase the likelihood of fractures from minor injuries.
• Osteoporosis Associated With Aging: Declining skeletal strength in older women and men that may require fracture risk evaluation and medical treatment.
• Osteopenia (Low Bone Density): Bone mineral density below the normal range but not sufficiently low to meet the bone-density criteria for osteoporosis.
• Secondary Osteoporosis: Bone weakening caused or worsened by underlying illnesses, endocrine disorders, or certain prescription medications.
• Increased Fragility Fracture Risk: Elevated likelihood of future fractures associated with previous low-trauma fractures, reduced bone density, or other clinical risk factors.
• Hormone-Related Bone Density Loss: Skeletal changes associated with thyroid disease, parathyroid dysfunction, or other hormonal abnormalities affecting bone metabolism.
• Medication-Related Osteoporosis: Assessment of bone loss associated with long-term use of certain medications, particularly systemic glucocorticoids.
• Progressive Bone Density Decline: Continued reductions in bone mineral density that may require reassessment of underlying causes or existing treatment effectiveness.

Not everyone diagnosed with osteopenia needs prescription osteoporosis medication. Treatment decisions should consider bone density measurements, previous fractures, estimated future fracture risk, and the patient’s overall medical circumstances.

Schedule a bone health consultation at DFWPMA Sherman to discuss osteoporosis, osteopenia, or concerns about fracture risk.

What Does Osteoporosis Care at DFWPMA Sherman Include?

Osteoporosis management at DFWPMA Sherman involves evaluating skeletal health, identifying factors that increase fracture risk, investigating possible medical causes of bone loss, and developing individualized treatment and follow-up recommendations.

Depending on the patient’s diagnosis, fracture risk, and medical needs, osteoporosis care may include:

• Bone Mineral Density Evaluation: Interpretation of dual-energy X-ray absorptiometry (DXA or DEXA) results to assess bone density and support diagnosis and ongoing monitoring.
• Individualized Fracture Risk Assessment: Review of age, prior fractures, family history, bone density measurements, and other factors that influence the likelihood of future fractures.
• Hormonal and Metabolic Testing: Appropriate laboratory evaluations to investigate possible contributors to bone loss, including thyroid dysfunction, abnormal calcium regulation, or parathyroid disorders.
• Bisphosphonate Treatment Evaluation: Consideration of medications such as alendronate, risedronate, or zoledronic acid for patients who meet clinical criteria for fracture prevention treatment.
• Other Osteoporosis Medication Options: Assessment of treatments such as denosumab or bone-building medications for selected patients based on fracture risk, medical history, and contraindications.
• Calcium and Vitamin D Recommendations: Review of dietary intake and nutritional requirements, with supplementation considered when appropriate for maintaining bone health.
• Physical Activity and Fall Prevention Guidance: Recommendations for suitable weight-bearing exercise, strength training, balance activities, and reducing environmental fall risks.
• Osteoporosis Medication Monitoring: Assessment of medication effectiveness, treatment adherence, potential adverse effects, and the need for changes in medical therapy.
• Long-Term Bone Health Follow-Up: Periodic reassessment of fracture risk, bone density when clinically indicated, and the ongoing need for osteoporosis treatment.

Prescription treatment for osteoporosis is selected according to fracture risk, kidney function, previous treatment, coexisting medical conditions, and other patient-specific considerations. Medication selection and treatment duration should reflect the individual’s clinical circumstances.

The American College of Physicians recommends bisphosphonates as initial medication treatment for postmenopausal women with primary osteoporosis and suggests them for men with primary osteoporosis. Other therapies may be appropriate when individual medical factors warrant a different approach.

Some osteoporosis medications require a carefully planned transition when discontinued. Patients should speak with their prescribing clinician before stopping, delaying, or changing osteoporosis treatment.

Looking for osteoporosis care in Sherman, Texas? Contact DFWPMA to schedule an appointment or call (903) 957-0082 to discuss bone density evaluations, fracture prevention, and individualized osteoporosis management with Dr. Gitana Staskus.